That is a point I had not thought of originally. Nonetheless, it's a weak "maybe" IMO as I believe the vast majority of institutional investors came in at levels below $4 ps.
It does not seem likely that a slew of new fund managers would have bought in the run-up to $7. Accordingly it doesn't seem likely there would be a lot of pressure from institutional investors ... at least not yet.
I hope I'm wrong, or that I'm missing something obvious like I usually do.
The major shareholders/players may not like the absence of the transparency in Portland, and even lower entry should not give them a peace of mind, having observed the serious mishap/setup by the Management in presenting the unique scientific trial that they, the Managers, soppose to conduct. Trust could be obused only once. Smart money stay only with smart handlers.
red ... are you being deliberately cryptic in even replying to this thread? I've noticed that on several of your posts since the ASM ... leading me to surmise that you've gotten a lot more involved in the business of AVII and not just the science. Hey, more power to you.